M Colucci, L Roccatagliata, E Capello, E Narciso, N Latronico, M Tabaton, and G L Mancardi

The 14-3-3 protein in multiple sclerosis: a marker of disease severity
Mult Scler 2004 10: 477-481. [Abstract] [PDF] [References]  

Wen-Xin Huang, Ping Huang, and Jan Hillert

Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple sclerosis
Mult Scler 2004 10: 482-487. [Abstract] [PDF] [References]  

Anat Achiron, Shmuel Edelstein, Y Ziev-Ner, Uri Givon, Zeev Rotstein, and Yoram Barak

Bone strength in multiple sclerosis: cortical midtibial speed-of-sound assessment
Mult Scler 2004 10: 488-493. [Abstract] [PDF] [References]  

Juan Feng, Tatsuro Misu, Kazuo Fujihara, Saburo Sakoda, Yuji Nakatsuji, Hikoaki Fukaura, Seiji Kikuchi, Kunio Tashiro, Akio Suzumura, Naoto Ishii, Kazuo Sugamura, Ichiro Nakashima, and Yasuto Itoyama

Ibudilast, a nonselective phosphodiesterase inhibitor, regulates Th1/Th2 balance and NKT cell subset in multiple sclerosis
Mult Scler 2004 10: 494-498. [Abstract] [PDF] [References]  

Ying CQ Zang, Sheri M Skinner, Rachel R Robinson, Sufang Li, Victor M Rivera, George J Hutton, and Jingwu Z Zhang

Regulation of differentiation and functional properties of monocytes and monocyte-derived dendritic cells by interferon beta in multiple sclerosis
Mult Scler 2004 10: 499-506. [Abstract] [PDF] [References]  

C Gneiss, M Reindl, A Lutterotti, R Ehling, R Egg, M Khalil, T Berger, and F Deisenhammer

Interferon-beta: the neutralizing antibody (NAb) titre predicts reversion to NAb negativity
Mult Scler 2004 10: 507-510. [Abstract] [PDF] [References]  

T L Vollmer, J T Phillips, A D Goodman, M A Agius, M A Libonati, J L Giacchino, and J S Grundy

An open-label safety and drug interaction study of natalizumab (Antegren^TM) in combination with interferon-beta (Avonex®) in patients with multiple sclerosis
Mult Scler 2004 10: 511-520. [Abstract] [PDF] [References]  

J F Nielsen and T Sinkjær

Guided intrathecal baclofen administration by using soleus stretch reflex in moderate-severe spastic multiple sclerosis patients with implanted pump
Mult Scler 2004 10: 521-525. [Abstract] [PDF] [References]  

Arash Kheradvar, Abdol Reza Tabassi, Behrouz Nikbin, Farideh Khosravi, Mehrnaz Naroueynejad, Batool Moradi, and Ali Akbar Amirzargar

Influence of HLA on progression of optic neuritis to multiple sclerosis: results of a four-year follow-up study
Mult Scler 2004 10: 526-531. [Abstract] [PDF] [References]  

D Otaegui, A Sáenz, M Martínez-Zabaleta, P Villoslada, I Fernández-Manchola, A álvarez de Arcaya, J I Emparanza, and A López de Munain

Mitochondrial haplogroups in Basque multiple sclerosis patients
Mult Scler 2004 10: 532-535. [Abstract] [PDF] [References]  

Radhika Gade-Andavolu, David E Comings, James MacMurray, Ravi K Vuthoori, Wallace W Tourtellotte, Rashed M Nagra, and Lawrence A Cone

RANTES: a genetic risk marker for multiple sclerosis
Mult Scler 2004 10: 536-539. [Abstract] [PDF] [References]  

Mathilde SA Deloire, Tarik Touil, Bruno Brochet, Vincent Dousset, Jean-Marie Caillé, and Klaus G Petry

Macrophage brain infiltration in experimental autoimmune encephalomyelitis is not completely compromised by suppressed T-cell invasion: in vivo magnetic resonance imaging illustration in effective anti-VLA-4 antibody treatment
Mult Scler 2004 10: 540-548. [Abstract] [PDF] [References]  

Richard HC Lazeron, Serge ARB Rombouts, Philip Scheltens, Chris H Polman, and Frederik Barkhof

An fMRI study of planning-related brain activity in patients with moderately advanced multiple sclerosis
Mult Scler 2004 10: 549-555. [Abstract] [PDF] [References]  

A Castriota-Scanderbeg, F Fasano, M Filippi, and C Caltagirone

T1 relaxation maps allow differentiation between pathologic tissue subsets in relapsing-remitting and secondary progressive multiple sclerosis
Mult Scler 2004 10: 556-561. [Abstract] [PDF] [References]  

Laura Locatelli, Robert Zivadinov, Attilio Grop, and Marino Zorzon

Frontal parenchymal atrophy measures in multiple sclerosis
Mult Scler 2004 10: 562-568. [Abstract] [PDF] [References]  

E LJ Hoogervorst, J NP Zwemmer, B Jelles, C H Polman, and B MJ Uitdehaag

Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability
Mult Scler 2004 10: 569-574. [Abstract] [PDF] [References]  

L J Edwards and C S Constantinescu

A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic
Mult Scler 2004 10: 575-581. [Abstract] [PDF] [References]  

P K Coyle, S Christie, P Fodor, K Fuchs, B Giesser, A Gutierrez, J Lynn, B Weinstock-Guttman, and L Pardo Women Neurologists MS Initiative (WNMSI)

Multiple sclerosis gender issues: clinical practices of women neurologists
Mult Scler 2004 10: 582-588. [Abstract] [PDF] [References]  

M A Rizzo, O C Hadjimichael, J Preiningerova, and T L Vollmer

Prevalence and treatment of spasticity reported by multiple sclerosis patients
Mult Scler 2004 10: 589-595. [Abstract] [PDF] [References]  

J de Seze, M Chapelotte, S Delalande, D Ferriby, T Stojkovic, and P Vermersch

Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis
Mult Scler 2004 10: 596-597. [Abstract] [PDF] [References]  

S Deftereos, D Farmakis, A Papadogianni, B Besleme, E Diamanti-Kandarakis, E Polymeropoylos, D Georgonikou, and A Aessopos

Waldenström's macroglobulinemia developing in a patient with multiple sclerosis: coincidence or association?
Mult Scler 2004 10: 598-600. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.